Status:
UNKNOWN
PRISM-GENOMICS-Smoking Cessation for Patients With Coronary Artery Disease Undergoing Cardiac Catheterization or Having a Heart Attack at Barnes Hospital in St. Louis Mo
Lead Sponsor:
Washington University School of Medicine
Conditions:
Coronary Artery Disease
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
It has previously been shown that patients with coronary artery disease may have a harder time quitting smoking if they have a specific genetic profile and that these individuals have a better chance ...
Detailed Description
In this study, the investigators propose to show the feasibility of incorporating genotype-guided therapy into post-MI smoking cessation therapy and/or smoking cessation therapy in patients with coron...
Eligibility Criteria
Inclusion
- Adult
- presenting to Barnes hospital cardiac catheterization laboratory with coronary artery disease or admitted to Barnes hospital within 24 hours of a type 1 myocardial infarction (heart attack)
- active smoker at time of presentation to Barnes Hospital
- participating in PRISM-GENOMICS observational study
Exclusion
- Unable to provide informed consent
- Unable to answer questions (e.g. intubated)
- Incarcerated
- Complications of myocardial infarction (such as shock, hemodynamic instability, life- threatening infection, etc)
- Women of child-bearing age with positive pregnancy test or who is breast feeding
Key Trial Info
Start Date :
July 21 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 21 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03383224
Start Date
July 21 2015
End Date
July 21 2025
Last Update
November 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barnes Hospital
St Louis, Missouri, United States, 63110